{
event: "article_read",
name: `Discover the science behind Tolebrutinib: a BTK inhibitor designed to slow MS disability progression by modulating adaptive and innate immunity`,
author: ``,
tags: `Multiple Sclerosis`,
publication_date: ``,
interaction_type: "content"
}
Discover the science behind Tolebrutinib: a BTK inhibitor designed to slow MS disability progression by modulating adaptive and innate immunity

Related articles
MAT-BH-2500365-V1-June 2025